Rosen's Breast Pathology, 4e

403

Ductal Carcinoma In Situ

the Istituto Europeo di Oncologia (IEO), Milan, Italy. Breast Cancer Res Treat 2011;128:369–378. 13. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of tumours of the breast . 4th ed. Lyon: World Health Organization-IARC, 2012. 14. www.cancer.org/cancer/breastcancer/detailedguide. Accessed June 30, 2013. 15. Sacchini V, Fortunato L, Cody III HS, et al. Breast ductal carcinoma in situ . Int J Surg Oncol 2012;2012:753267. 16. Rosen PP. The pathological classification of human mammary carci- noma: past, present and future. Ann Clin Lab Sci 1979;9:144–156. 17. Smart CR, Myers MH, Gloecker LA. Implications from SEER data on breast cancer management. Cancer 1978;41:787–789. 18. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913–918. 19. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 1997;(22):151–156. 20. Winchester DJ, Menck HR, Winchester DP. National treatment trends for ductal carcinoma in situ of the breast. Arch Surg 1997;132:660–665. 21. Blichert-Toft M, Graversen HP, Andersen J, et al. In situ breast carci- nomas: a population-based study on frequency, growth pattern, and clinical aspects. World J Surg 1988;12:845–851. 22. Ward BA, McKhann CF, Ravikumar TS. Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg 1992;127:1392–1395. 23. Adams-Cameron M, Gilliland FD, Hunt WC, et al. Trends in in- cidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non-Hispanic white women in New Mexico, 1973–1994. Cancer 1999;85:1084–1090. 24. Shamliyan T, Wang SY, Virnig BA, et al. Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ . J Natl Cancer Inst Monogr 2010;2010(41):121–129. 25. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88:1571–1579. 26. Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010;102:170–178. 27. Kerlikowske K, Barclay J, Grady D, et al. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 1997;89:76–82. 28. Weiss HA, Brinton LA, Brogan D, et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 1996;73:1298–1305. 29. Virnig BA, Wang SY, Shamilyan T, et al. Ductal carcinoma in situ : risk factors and impact of screening. J Natl Cancer Inst Monogr 2010;2010(41):113–116. 30. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480–1490. 31. Hall MJ, Reid JE, Wenstrup RJ. Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma in situ and referred for genetic testing. Cancer Prev Res (Phila) 2010;3:1579–1585. 32. Ciatto S, Bonardi R, Cataliotti L, et al. Intraductal breast carcinoma. Review of a multicenter series of 350 cases. Tumori 1990;76:552–554. 33. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546–1554. 34. Andersson I. Breast cancer screening in Malmo. Recent Results in Can- cer Res 1984;90:114–116. 35. Andersson I, Andren L, Hildell J, et al. Breast cancer screening with mammography. A population-based randomized trial with mammog- raphy as the only screening mode. Radiology 1979;132:273–276. 36. Hendricks JHCL. Population Screening for Breast Cancer by Means of Mammography in Nijmegen , 1975–1982. [M.D. Thesis]. Nijmegen University; 1982. 37. Lewis JD, Milbrath JR, Shaffer KA, et al. Implications of suspicious findings in breast cancer screening. Arch Surg 1975;110:903–907. 38. Sigfusson BF, Anderson I, Aspergren K, et al. Clustered breast calcifi- cations. Acta Radiol 1983;24:273–281. 39. Tabar L, Akerlund E, Gad A. Five-year experience with single-view mammography randomized controlled screening in Sweden. Recent Results in Cancer Res 1984;90:105–113. 40. Verbeek ALM, Hendriks JHCL, Holland R, et al. Reduction of breast cancer mortality through mass screening with modern

mammography: first results of the Nijmegen Project, 1975–1981. Lan- cet 1984;1:1222–1224. 41. Ciatto S, Cataliotti L, Distante V. Nonpalpable lesions detected with mammography: review of 512 consecutive cases. Radiology 1987;165:99–102. 42. Meyer JS. Cell kinetics of histologic variants of in situ breast carci- noma. Breast Cancer Res Treat 1986;7:171–180. 43. Patchefsky AS, Shaber GS, Schwartz GF, et al. The pathology of breast cancer detected by mass population screening. Cancer 1977;40:1659–1670. 44. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ : mammographic findings and clinical implications. Radiology 1989;170:411–415. 45. Ikeda DM, Andersson I. Atypical mammographic presentation of ductal carcinoma in situ . Radiology 1989;172:661–666. 46. Stomper PC, Connolly JL, Meyer JE, et al. Clinically occult ductal car- cinoma in situ detected with mammography: analysis of 100 cases with radiologic–pathologic correlation. Radiology 1989;172:235–241. 47. D’Orsi CJ. Imaging for the diagnosis and management of ductal carci- noma in situ . J Natl Cancer Inst Monogr 2010;2010(41):214–217. 48. Carlson KL, Helvie MA, Roubidoux MA, et al. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ . AJR Am J Roentgenol 1999;172:313–317. 49. Holland R, Hendriks JHCL, Verbeek ALM, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carci- noma in situ . Lancet 1990;335:519–522. 50. Lagios MD. Multicentricity of breast carcinoma demonstrated by routine correlated subgross and radiographic examination. Cancer 1977;40:1726–1734. 51. Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: cor- relation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 1992;159:483–485. 52. Parker J, Dance DR, Davies DH, et al. Classification of ductal carci- noma in situ by image analysis of calcifications from digital mammo- grams. Br J Radiol 1995;68:150–159. 53. Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 1994;162:1307–1311. 54. Evans AJ, Pinder SE, Ellis IO, et al. Correlations between the mam- mographic features of ductal carcinoma in situ (DCIS) and c-erb-s oncogene expression. Clin Radiol 1994;49:559–562. 55. Han JS, Molberg KH, Sarode V. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of duc- tal carcinoma in situ : an analysis of 255 cases. Breast J 2011;17:223–229. 56. Ciatto S, Grazzini G, Iossa A, et al. In situ ductal carcinoma of the breast—analysis of clinical presentation and outcome in 156 consecu- tive cases. Eur J Surg Oncol 1990;16:220–224. 57. Mitnick JS, Roses DF, Harris MN, et al. Circumscribed intraductal carcinoma of the breast. Radiology 1989;170:423–425. 58. Park JS, Park YM, Kim EK, et al. Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast. J Ultra- sound Med 2010;29:1687–1697. 59. Reiff DB, Cooke J, Griffin M, et al. Ductal carcinoma in situ presenting as a stellate lesion on mammography. Clin Radiology 1994;49:396–399. 60. Menell JH, Morris EA, Dershaw DD, et al. Determination of the pres- ence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005;11:382–390. 61. Gilles R, Zafrani B, Guinebretiere J-M,et al. Ductal carcinoma in situ : MRimaging-histopathologiccorrelation. Radiology 1995;196:415–419. 62. Orel S, SchnallM, Livolsi V, et al. Suspicious breast lesions:MR imaging with radiologic–pathologic correlation. Radiology 1994;190:485–493. 63. Heywang-Köbrunner S. Contrast-enhanced magnetic resonance im- aging of the breast. Invest Radiol 1994;29:94–104. 64. Orel SG, Mendonca MH, Reynolds C, et al. MR imaging of ductal car- cinoma in situ . Radiology 1997;202:413–420. 65. Pediconi F, Catalano C, Roselli A, et al. Contrast-enhanced MR mam- mography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007;243:670–680. 66. Londero V, Zuiani C, Linda A, et al. High-risk breast lesions at imag- ing-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol 2012;199:W240–W250. 67. Kuhl CK. Why do purely intraductal cancers enhance on breast MR images? Radiology 2009;253:281–283.